Literature DB >> 20507764

The wages of original antigenic sin.

David M Morens1, Donald S Burke, Scott B Halstead.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507764      PMCID: PMC3086238          DOI: 10.3201/eid1606.100453

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
“The deliberate sin of the first man is the cause of original sin” —[Saint] Augustine of Hippo, Algerian Christian theologian (354 ad–430 ad), De nuptiis et concupiscientia [On Marriage and Concupiscence], II, xxvi, 43 What epidemiologist Thomas Francis, Jr. (1900–1969) was thinking when pondering certain inexplicable serologic data from a 1946 influenza vaccine trial may never be known. Whether in religious reverence for the beauty of science or impish delight fueled by the martini breaks of which he was so fond, Francis coined the term “original antigenic sin” to describe a curious new immunologic phenomenon. Elsewhere in this issue, Adalja and Henderson propose that original antigenic sin has altered the population age–specific incidence of infection and disease caused by influenza A pandemic (H1N1) 2009 virus and that public health responses must account for the disruption (). What is original antigenic sin, what is its immunologic basis, and into what sort of trouble is it getting us? Discovery of influenza viruses in the early 1930s ignited a search to understand the epidemiology of pandemic/endemic influenza. Serologic data showed that decendents of the 1918 pandemic influenza virus were still circulating and were changing antigenically (we would now say drifting and undergoing intrasubtypic reassortment); that contemporary human and swine viruses were closely related; and that over a lifetime of repeated exposures, different human birth cohorts were acquiring fundamentally different influenza infection experiences. The surprise appearance in 1946 of a new and antigenically different influenza A virus (designated influenza A′ and recently shown to be a subtype H1N1 intrasubtypic reassortant) provided Francis a unique opportunity. College students participating in a 1946 trial of the old 1946 virus vaccine were infected in March 1947 with the new A′ virus. Surprisingly, these students developed low serologic titers to the new infecting virus and higher seroconverting titers to old viruses with which they previously had been infected. Moreover, recent recipients of the old virus vaccine had the highest seroconverting titers of all to the old—but not to the new—virus (,). Absorption studies, in which various viruses were used to selectively remove serum antibodies, suggested that repeat exposures to dominant antigens of first-infecting viruses, when seen later as lesser or secondary antigens on subsequently infecting viruses, somehow reinforced antibody responses to the original strains at the apparent expense of responses to newer strains (). Francis announced “the doctrine of original antigenic sin” (,): “[t]he antibody-forming mechanisms appear to be oriented by the initial infections of childhood so that exposures later in life to antigenically related strains result in a progressive reinforcement of the primary antibody” (). Later studies by many investigators showed original antigenic sin to be a general phenomenon associated with numerous related/sequentially infecting virus strains that contain multiple external epitopes of varying cross-specificity (i.e., ability to elicit cross-reactive antibody), including antigenically drifting viruses such as influenza A, and the more stable flaviviruses, which circulate concurrently as multiple distinct viruses, virus serotypes, and virus strains (,). Original antigenic sin seems to be most pronounced when sequential viruses are of intermediate antigenic relatedness; when they are antigenically complex; and when sequential exposure intervals are long, consistent with ongoing selection and expansion of lymphocyte clones that have increasing antibody avidity at key cross-reactive epitopes (–) and possibly with epitope competition between naïve and antigen-specific B cells (). A phenomenon analogous to original antigenic sin also has been described with cytotoxic T lymphocytes (). Although conclusive evidence in humans is lacking, original antigenic sin recently has come under scrutiny as a possible cause of viral immune escape, enhanced disease severity, decreased efficacy of influenza vaccines (8,12–14), and increased incidence of influenza in 2009 after vaccination with a related virus in 2008–2009 (15). On a positive note, original antigenic sin has also been linked to vaccine-induction of heterosubtypic neutralizing antibodies (16). Adalja and Henderson note that the apparently lower incidence and severity of disease in older persons during the 2009–10 influenza pandemic probably reflects immunity to previously circulating influenza (H1N1) subtypes (). Reichert et al. also attribute this age structure to original antigenic sin but emphasize the importance of exposures to the changing hemagglutinin glycosylation patterns of earlier influenza (H1N1) subtypes (e.g., those circulating before and after 1948) on a background of relatively conserved T-cell epitopes (). However, the possibility that the age structure of pandemic (H1N1) 2009 infection is due simply to single or repeated exposures to different or differentially exposed hemagglutinin epitopes has not been ruled out. Useful information bearing on these questions might be gained by comparing antibody levels, antibody reactivities, and the original antigenic sin phenomenon in serum samples from the various age cohorts that had early exposures to markedly different (or to no) influenza (H1N1) serotypes, e.g., persons born before 1918; during 1918–1927, 1928–1946, 1947–1956, and 1957–1976; and after 1976. Of related interest are the 2009 influenza experiences of the ≈25.6 million persons living in America vaccinated with the 1976 Hsw1N1 vaccine (), including 2.5 million born during 1957–1975, when influenza (H1N1) viruses did not circulate The current pandemic provides the challenge to public health responses that Adjala and Henderson describe, as well as an opportunity to extend the efforts of Francis to better understand the complicated epidemiology of influenza. Is original antigenic sin really a sin from which our immune systems need to be saved? Or is it an epidemiologic blessing in disguise? We have much more to learn. As St. Augustine wrote (Confessiones, 8, 7): “Lord make me chaste—but not yet.”
  16 in total

1.  The current status of the control of influenza.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1955-09       Impact factor: 25.391

2.  Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report.

Authors:  T Francis; J E Salk; J J Quilligan
Journal:  Am J Public Health Nations Health       Date:  1947-08

3.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin".

Authors:  D C Powers; R B Belshe
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

5.  Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination.

Authors:  Upma Gulati; Kshama Kumari; Wenxin Wu; Wendy A Keitel; Gillian M Air
Journal:  Vaccine       Date:  2005-02-03       Impact factor: 3.641

6.  Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus.

Authors:  John C Kash; Li Qi; Vivien G Dugan; Brett W Jagger; Rachel J Hrabal; Matthew J Memoli; David M Morens; Jeffery K Taubenberger
Journal:  Influenza Other Respir Viruses       Date:  2010-05-01       Impact factor: 4.380

7.  Original antigenic sin in dengue.

Authors:  S B Halstead; S Rojanasuphot; N Sangkawibha
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

8.  Original antigenic sin responses to influenza viruses.

Authors:  Jin Hyang Kim; Ioanna Skountzou; Richard Compans; Joshy Jacob
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

9.  Characterization of influenza antibodies by serum absorption.

Authors:  K E JENSEN; F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

10.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  27 in total

1.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

3.  Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology.

Authors:  Ikuo Tsunoda; Seiichi Omura; Fumitaka Sato; Susumu Kusunoki; Mitsugu Fujita; Ah-Mee Park; Faris Hasanovic; Richard Yanagihara; Satoshi Nagata
Journal:  Acta Med Kinki Univ       Date:  2016

4.  Helminth infection alters IgE responses to allergens structurally related to parasite proteins.

Authors:  Helton da Costa Santiago; Flávia L Ribeiro-Gomes; Sasisekhar Bennuru; Thomas B Nutman
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

Review 5.  Zika Virus Infection: Current Concerns and Perspectives.

Authors:  Mari Kannan Maharajan; Aruna Ranjan; Jian Feng Chu; Wei Lim Foo; Zhi Xin Chai; Eileen YinYien Lau; Heuy Mien Ye; Xi Jin Theam; Yen Ling Lok
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

6.  First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

Authors:  Lindsey R Baden; Stephen R Walsh; Michael S Seaman; Yehuda Z Cohen; Jennifer A Johnson; J Humberto Licona; Rachel D Filter; Jane A Kleinjan; Jon A Gothing; Julia Jennings; Lauren Peter; Joseph Nkolola; Peter Abbink; Erica N Borducchi; Marinela Kirilova; Kathryn E Stephenson; Poonam Pegu; Michael A Eller; Hung V Trinh; Mangala Rao; Julie A Ake; Michal Sarnecki; Steven Nijs; Katleen Callewaert; Hanneke Schuitemaker; Jenny Hendriks; Maria G Pau; Frank Tomaka; Bette T Korber; Galit Alter; Raphael Dolin; Patricia L Earl; Bernard Moss; Nelson L Michael; Merlin L Robb; Dan H Barouch
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

7.  Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.

Authors:  Shabnam Alam; Andrea J Sant
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

8.  The 2009 H1N1 pandemic influenza virus: what next?

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  MBio       Date:  2010-09-28       Impact factor: 7.867

9.  Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009.

Authors:  Peng Wu; Edward Goldstein; Lai Ming Ho; Lin Yang; Hiroshi Nishiura; Joseph T Wu; Dennis K M Ip; Shuk-Kwan Chuang; Thomas Tsang; Benjamin J Cowling
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

10.  Quantitative modeling of the effect of antigen dosage on B-cell affinity distributions in maturating germinal centers.

Authors:  Simona Cocco; Rémi Monasson; Marco Molari; Klaus Eyer; Jean Baudry
Journal:  Elife       Date:  2020-06-15       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.